Supernus Names Tony Kingsley Board Chair Following Indivior Merger

• Supernus named former Indivior director Tony Kingsley board chair following completion of the companies' merger on November 2, 2026.
• The combined company's eight-member board includes four directors from each legacy company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Supernus Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-121014), on November 02, 2026, and is solely responsible for the information contained therein.